Authors should kindly note that the manuscript is required to be prepared by Microsoft Word template.
Please provide your name, email address, and affiliation, and other contact details the publication might require, which will be used for the regular operations of the publication. The publication and the publisher have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed.
Manuscript submission to Molecular Biology & Nanomedicine will imply that it is an unpublished work, which is not being considered for publication elsewhere including in another journal or book, in either the same or another format or language.
Please submit your article via the email email@example.com.
The main article types are as follows:
The articles published in the Molecular Biology & Nanomedicine are not limited on the length of manuscripts, though the Journal still require the text is concise and comprehensive. To ensure the results can be reproduced, full experimental details must be provided.
Manuscript submissions should include a cover letter. The cover letter must state:
Please see the template for more information.
All the submitted manuscripts are required to be presented with clear, cohesive and good English. Authors whose first language is not English are advised to have their manuscripts edited by a native English speaker before submission to ensure the high quality of expression. Or please contact firstname.lastname@example.org for scientific English correction. This service will be paid for and arranged by the author.
Molecular Biology & Nanomedicine is a full open access journal, free for readers. At present, there are no fees for submission, processing, and publication to the authors or their institutions.
The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high-quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Cancer Molecular Biology & Nanomedicine take such publishing ethics issues very seriously and are trained to proceed in such cases with zero tolerance policy.
Plagiarism involves the inclusion of large sections of unaltered or minimally altered text from an existing source without appropriate and unambiguous attribution, and/or an attempt to misattribute original authorship regarding ideas or results, and copying text, images, or data from another source, even from your own publications, without giving credit to the source. As to reusing the text that is copied from another source, it must be between quotation marks and the source must be cited. If a study's design or the manuscript's structure or language has been inspired by previous studies, these studies must be cited explicitly.
Plagiarism is not acceptable in this journal. Techland publishing has a partnership with iThenticate, which is the most trusted similarity checker. It is used to analyze received manuscripts to avoid plagiarism to the greatest extent possible. If plagiarism is detected during the peer-review process, the manuscript may be rejected. If plagiarism is detected after publication, we may publish a Correction or retract the paper.